Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec 31;12(12):CD012173.
doi: 10.1002/14651858.CD012173.pub2.

Restriction of salt, caffeine and alcohol intake for the treatment of Ménière's disease or syndrome

Kiran Hussain  1 , Louisa Murdin, Anne Gm Schilder
Affiliations

Restriction of salt, caffeine and alcohol intake for the treatment of Ménière's disease or syndrome

Kiran Hussain et al. Cochrane Database Syst Rev. .

Abstract

Background: Ménière's disease or syndrome is a chronic inner ear disorder that results in sporadic attacks of vertigo, sensorineural hearing loss, aural fullness and tinnitus.There is no definitive treatment for Ménière's disease and treatment options range from dietary modification through medication to surgery.Modification of diet, including restriction of salt, caffeine and alcohol intake, is a management option that is widely recommended to patients with Ménière's as a first-line treatment. There has not previously been a systematic review of this intervention.

Objectives: To assess the effects of dietary restriction of salt, caffeine and alcohol intake in patients with Ménière's disease or syndrome.

Search methods: The Cochrane ENT Information Specialist searched the Cochrane ENT Trials Register; Central Register of Controlled Trials (CENTRAL); PubMed; Ovid Embase; CINAHL; Web of Science; ClinicalTrials.gov; ICTRP and additional sources for published and unpublished trials. The date of the search was 28 March 2018.

Selection criteria: Randomised controlled trials of dietary modification, specifically salt, caffeine and alcohol restriction or substitution (or both), compared to no modification of these agents or a placebo intervention, in adult patients with Ménière's disease or syndrome.

Data collection and analysis: We used the standard methodological procedures expected by Cochrane. Our primary outcomes were control of vertigo or decrease in vertigo attacks, and adverse effects. Secondary outcomes included hearing (change in hearing loss or its progression), tinnitus (severity), perception of aural fullness, well-being and quality of life (overall changes), and other adverse effects. We planned to use GRADE to assess the quality of the evidence for each outcome.

Main results: We did not identify any studies that met the inclusion criteria for the review.

Authors' conclusions: There is no evidence from randomised controlled trials to support or refute the restriction of salt, caffeine or alcohol intake in patients with Ménière's disease or syndrome.High-quality research in this field is warranted. The best evidence may come from a randomised controlled trial comparing dietary interventions (e.g. low salt versus general healthy diet advice), using rigorous methodology for patient selection, randomisation and blinding, and strictly adhering to the Bárány Society diagnostic criteria. However, this research question might be more pragmatically addressed by using information from carefully constructed patient registries that include information on dietary intake of substances of interest such as salt, caffeine and alcohol. It will be important to address the question of any possible harms or unwanted effects of dietary modification.

PubMed Disclaimer

Conflict of interest statement

Kiran Hussain: Kiran Hussain is a recipient of a small grant from the Ménière's Society (charity).

Louisa Murdin: none known.

Anne GM Schilder: Professor Anne Schilder is joint Co‐ordinating Editor of Cochrane ENT, but had no role in the editorial process for this review. Her evidENT team at UCL is supported in part by the National Institute of Health Research University College London Hospitals Biomedical Research Centre. Their research is funded by the NIHR and EU Horizon2020. She is the national chair of the NIHR Clinical Research Network ENT Specialty. She is the Surgical Specialty Lead for ENT for the Royal College of Surgeons of England's Clinical Trials Initiative. She is co‐investigator on the NIHR PGfAR grant 'Defining best Management for Adults with Chronic RhinOsinusitis: the MACRO Programme'. In her role as director of the NIHR UCLH BRC Deafness and Hearing Problems Theme, she acts as an advisor on clinical trial design and delivery to a range of biotech companies.

Figures

1
1
Process for sifting search results and selecting studies for inclusion.
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD012173

References

References to studies excluded from this review

Acharya 2017 {published data only}
    1. Acharya A, Singh MM, Shrestha A. First line treatment of Meniere's disease: a randomized controlled trial. Journal of Lumbini Medical College 2016;4(2):68‐71.
Bittar 2016 {published data only}
    1. Bittar RS, Santos MD, Mezzalira R. Glucose metabolism disorders and vestibular manifestations: evaluation through computerized dynamic posturography. Brazilian Journal of Otorhinolaryngology 2016;82(4):372‐6. - PMC - PubMed

Additional references

Alexander 2010
    1. Alexander TH, Harris JP. Current epidemiology of Meniere's syndrome. Otolaryngologic Clinics of North America 2010;43(5):965‐70. - PubMed
Alford 1972
    1. Alford BR. Disease: criteria for diagnosis and evaluation of therapy for reporting. Report of subcommittee on equilibrium and its measurement. Transactions of the American Academy of Ophthalmology and Otolaryngology 1972;76:1462‐4. - PubMed
Burgess 2006
    1. Burgess S, Kundu S. Diuretics for Ménière's disease or syndrome. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD003599.pub2] - DOI - PMC - PubMed
da Costa 2002
    1. Costa SS, Sousa LC, Piza MR. Meniere's disease: overview, epidemiology and natural history. Otolaryngologic Clinics of North America 2002;35(3):455‐95. - PubMed
Dederding 1929
    1. Dederding D. Clinical and experimental examination in patients suffering from morbus Meniere including study of problems of bone conduction. Acta Oto‐Laryngologica 1929;10:1‐156.
Furstenberg 1934
    1. Furstenberg AC, Lashmet FH, Lathrop F. Meniere's symptom complex: medical treatment. Annals of Otology, Rhinology and Laryngology 1934;43:1035‐47. - PubMed
Furstenberg 1941
    1. Furstenberg AC, Richardson G, Lathrop FD. Meniere's disease: addenda to medical therapy. Archives of Otolaryngology 1941;34:1038‐92.
Graudal 2017
    1. Graudal N, Hubeck‐Graudal T, Jurgens G. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride. Cochrane Database of Systematic Reviews 2017, Issue 4. [DOI: 10.1002/14651858.CD004022.pub4] - DOI - PMC - PubMed
Hallpike 1938
    1. Hallpike C, Cairns H. Observations on the pathology of Menière's syndrome. Journal of Laryngology and Otology 1938;53:625‐55. - PMC - PubMed
Handbook 2011
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Harcourt 2014
    1. Harcourt J, Barraclough K, Bronstein AM. Meniere's disease. BMJ 2014;12:g6544. - PubMed
James 2001
    1. James A, Burton M. Betahistine for Ménière's disease or syndrome. Cochrane Database of Systematic Reviews 2001, Issue 1. [DOI: 10.1002/14651858.CD001873] - DOI - PMC - PubMed
JLA 2011
    1. James Lind Alliance Priority Setting Partnerships. Ear, Nose and Throat (Aspects of Balance) Top 10. http://www.jla.nihr.ac.uk/priority‐setting‐partnerships/ear‐nose‐and‐thr... 2011.
Klockhoff 1974
    1. Klockhoff I, Lindbloom U, Stahle J. Diuretic treatment of Meniere's disease: long‐term results with chlorothiazide. Archives of Otolaryngology 1974;100:262‐5. - PubMed
Lopez‐Escamez 2016
    1. Lopez‐Escamez JA, John C, Won‐Ho C, Joel AG, Måns M, Marco M, et al. Diagnostic criteria for Menière's disease. Consensus document of the Bárány Society, the Japan Society for Equilibrium Research, the European Academy of Otology and Neurotology (EAONO), the American Academy of Otolaryngology‐Head and Neck Surgery (AAO‐HNS) and the Korean Balance Society. Acta Otorrinolaringologica Espanoloa 2016;67(1):1‐7. - PubMed
Luxford 2013
    1. Luxford E, Berliner KI, Lee J, Luxford WM. Dietary modification as adjunct treatment in Ménière's disease: patient willingness and ability to comply. Otology & Neurotology 2013;34(8):1438‐43. - PubMed
Moffat 1997
    1. Moffat DA, Ballagh RH. Menière's disease. In: Kerr AG, Booth JB editor(s). Scott‐Brown's Otolaryngology. 3rd Edition. Vol. 3, Oxford: Butterworth‐Heinemann, 1997:1‐50.
Murdin 2015
    1. Murdin L, Schilder AS. Epidemiology of balance system disorders in the community: a systematic review. Otology Neuro‐otology 2015;36(3):387‐92. - PubMed
Ménière's Guide 1995
    1. No authors listed. Committee on Hearing and Equilibrium. Guidelines for the diagnosis and evaluation of therapy in Menière's disease. Otolaryngology ‐ Head and Neck Surgery 1995;113:181‐5. - PubMed
Ménière's Society
    1. Ménière's Society. Other non‐surgical treatments. https://www.menieres.org.uk/ (accessed prior to 8 August 2018).
NHS 2017
    1. NHS. Ménière's disease. https://www.nhs.uk/conditions/menieres‐disease/ (accessed 22 October 2018).
Office of National Statistics
    1. Office of National Statistics. Adult drinking habits in England. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/... (accessed prior to 8 August 2018).
Pearson 1985
    1. Pearson BW, Brackmann DE. Committee on hearing and equilibrium guidelines for reporting treatment results in Menière's disease. Otolaryngology ‐ Head and Neck Surgery 1985;93:578‐81. - PubMed
Pesta 2013
    1. Pesta DH, Angadi SS, Burtscher M, Roberts CK. The effects of caffeine, nicotine, ethanol, and tetrahydrocannabinol on exercise performance. Nutrition and Metabolism 2013;10(1):71. - PMC - PubMed
Phillips 2011
    1. Phillips JS, Westerberg B. Intratympanic steroids for Ménière's disease or syndrome. Cochrane Database of Systematic Reviews 2011, Issue 7. [DOI: 10.1002/14651858.CD008514.pub2] - DOI - PubMed
Pullens 2011
    1. Pullens B, Benthem PP. Intratympanic gentamicin for Ménière's disease or syndrome. Cochrane Database of Systematic Reviews 2011, Issue 3. [DOI: 10.1002/14651858.CD008234.pub2] - DOI - PubMed
Pullens 2013
    1. Pullens B, Verschuur HP, Benthem PP. Surgery for Ménière's disease. Cochrane Database of Systematic Reviews 2013, Issue 2. [DOI: 10.1002/14651858.CD005395.pub3] - DOI - PMC - PubMed
RevMan 2014 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Salvador‐Carulla 2010
    1. Salvador‐Carulla L, Gasca VI. Defining disability functioning autonomy and dependency in person‐centered medicine and integrated care. International Journal of Integrated Care 2010;10 Suppl:e025. - PMC - PubMed
Santos 1993
    1. Santos PM, Hall RA, Snyder JM, Hughes LF, Dobie RA. Diuretic and diet effect on Menière's disease evaluated by the 1985 Committee on Hearing and Equilibrium guidelines. Otolaryngology ‐ Head and Neck Surgery 1993;109(4):680‐9. - PubMed
Silverstein 1989
    1. Silverstein H, Smouha E, Jones R. Natural history versus surgery for Menière's disease. Otolaryngology ‐ Head and Neck Surgery 1989;100:6‐16. - PubMed
Stahle 1984
    1. Stahle J. Medical treatment of fluctuant hearing loss in Meniere's disease. American Journal of Otology 1984;5(6):529‐33. - PubMed
Stern 2010
    1. Stern TA, Gross AF, Stern TW, Nejad SH, Maldonado JR. Current approaches to the recognition and treatment of alcohol withdrawal and delirium tremens: "old wine in new bottles" or "new wine in old bottles". Primary Care Companion to the Journal of Clinical Psychiatry 2010;12(3):PCC.10r00991. - PMC - PubMed
Thompson 2010
    1. Thompson CJ. Hyponatraemia: new associations and new treatments. European Journal of Endocrinology 2010;162:S1‐S3. - PubMed
Trinidade 2014
    1. Trinidade A, Robinson T, Phillips JS. The role of caffeine in otorhinolaryngology: guilty as charged?. European Archives of Oto‐Rhino‐Laryngology 2014;271(8):2097‐102. - PubMed
Truswell 2005
    1. Truswell AS. Some problems with Cochrane reviews of diet and chronic disease. European Journal of Clinical Nutrition 2005;59 Suppl 1:S150‐4; discussion S195‐6. - PubMed
Tyrrell 2016
    1. Tyrrell J, Whinney DJ, Taylor T. The cost of Meniere's disease: a novel multisource approach. Ear and Hearing 2016;37(3):202‐9. - PubMed

References to other published versions of this review

Hussain 2016
    1. Hussain K, Murdin L, Schilder AGM. Restriction of salt intake and other dietary modifications for the treatment of Ménière's disease or syndrome. Cochrane Database of Systematic Reviews 2016, Issue 5. [DOI: 10.1002/14651858.CD012173] - DOI - PMC - PubMed

Publication types